Cytophage Technologies Ltd.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
7.4M
P/E Ratio
-
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada.
Healthcare
Biotechnology
TSXV
Key Financial Metrics
-
Revenue
-7.9M
Net Income
C$-0.15
EPS (Diluted)
-6.1M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-
Net Profit Margin
-
EBITDA
-7.1M
Returns & Efficiency
Return on Assets (ROA)
-159.2%
Return on Equity (ROE)
-268.2%
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
4.9M
Total Debt
1.5M
Debt to Equity
0.52x
Current Ratio
2.67
Company Info
| Industry | Biotechnology |
| HQ | Oak Bluff, Canada |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | cytophage.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
2,037,500
Shares Sold
0
Total Transactions
22
Interactive Charts
Company Profile
General Information
| Company Name | Cytophage Technologies Ltd. |
| Ticker | CYTO.V |
| Exchange | TSXV |
| Sector | Healthcare |
| Industry | Biotechnology |
| Headquarters | Oak Bluff, Canada |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | cytophage.com |
Financial Summary
| Market Cap | 7.4M |
| Revenue | N/A |
| Net Income | -7.9M |
| P/E Ratio | N/A |
| EPS (Diluted) | C$-0.15 |
| Net Margin | N/A |
| ROE | -268.2% |
| Dividend Yield | N/A |
Business Description
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada.